Apotex Health rises on TSX after IPO block grows by C$620 million following Cumberland deal
Apotex Health Corp. climbed 4.75% Friday to C$33.95, a new record close since its June debut. Canada’s S&P/TSX Composite Index also gained, finishing up 0.9% at 35,274.84. Trading volume was light for Apotex. Just 146,773 shares traded, well below its 65-day average, though the stock did hit a fresh intraday high at C$34.38.